Book contents
- Stahl’s Essential Psychopharmacology
- Additional material
- Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Preface to the Fifth Edition
- CME Information
- 1 Chemical Neurotransmission
- 2 Transporters, Receptors, and Enzymes as Targets of Psychopharmacological Drug Action
- 3 Ion Channels as Targets of Psychopharmacological Drug Action
- 4 Psychosis, Schizophrenia, and the Neurotransmitter Networks Dopamine, Serotonin, and Glutamate
- 5 Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond: So-Called “Antipsychotics”
- 6 Mood Disorders and the Neurotransmitter Networks Norepinephrine and γ-Aminobutyric Acid (GABA)
- 7 Treatments for Mood Disorders: So-Called “Antidepressants” and “Mood Stabilizers”
- 8 Anxiety, Trauma, and Treatment
- 9 Chronic Pain and Its Treatment
- 10 Disorders of Sleep and Wakefulness and Their Treatment: Neurotransmitter Networks for Histamine and Orexin
- 11 Attention Deficit Hyperactivity Disorder and Its Treatment
- 12 Dementia: Causes, Symptomatic Treatments, and the Neurotransmitter Network Acetylcholine
- 13 Impulsivity, Compulsivity, and Addiction
- Suggested Reading and Selected References
- Index
6 - Mood Disorders and the Neurotransmitter Networks Norepinephrine and γ-Aminobutyric Acid (GABA)
Published online by Cambridge University Press: 19 October 2021
- Stahl’s Essential Psychopharmacology
- Additional material
- Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Preface to the Fifth Edition
- CME Information
- 1 Chemical Neurotransmission
- 2 Transporters, Receptors, and Enzymes as Targets of Psychopharmacological Drug Action
- 3 Ion Channels as Targets of Psychopharmacological Drug Action
- 4 Psychosis, Schizophrenia, and the Neurotransmitter Networks Dopamine, Serotonin, and Glutamate
- 5 Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond: So-Called “Antipsychotics”
- 6 Mood Disorders and the Neurotransmitter Networks Norepinephrine and γ-Aminobutyric Acid (GABA)
- 7 Treatments for Mood Disorders: So-Called “Antidepressants” and “Mood Stabilizers”
- 8 Anxiety, Trauma, and Treatment
- 9 Chronic Pain and Its Treatment
- 10 Disorders of Sleep and Wakefulness and Their Treatment: Neurotransmitter Networks for Histamine and Orexin
- 11 Attention Deficit Hyperactivity Disorder and Its Treatment
- 12 Dementia: Causes, Symptomatic Treatments, and the Neurotransmitter Network Acetylcholine
- 13 Impulsivity, Compulsivity, and Addiction
- Suggested Reading and Selected References
- Index
Summary
This chapter discusses disorders characterized by abnormalities of mood: namely, depression, mania, or mixtures of both. Included here are descriptions of a wide variety of mood disorders that occur over a broad clinical spectrum. Clinical descriptions and criteria for how to diagnose disorders of mood will only be mentioned in passing. The reader should consult standard reference sources for this material. Also included in this chapter is an analysis of how monoamine neurotransmitter systems have long been hypothetically linked to the biological basis of mood disorders. We will also cover more recent advances in neurobiology that link mood disorders to glutamate, GABA (γ-aminobutyric acid), neurotrophic factors, neuroinflammation, and stress.
- Type
- Chapter
- Information
- Stahl's Essential PsychopharmacologyNeuroscientific Basis and Practical Applications, pp. 244 - 282Publisher: Cambridge University PressPrint publication year: 2021